title: Pharmacokinetic characterization of the postdistribution phase of prohormone atrial natriuretic peptides amino acids 1-98, 31-67, and atrial natriuretic factor during and after rapid right ventricular pacing in dogs.
abstract: Release rate constants and disappearance rate constants were determined for three atrial natriuretic peptides consisting of amino acids 1-98 (i.e., proANF 1-98), the midportion of the ANF prohormone consisting of amino acids 31-67 (i.e., proANF 31-67) and amino acids 99-126 (i.e., ANF) after right ventricular pacing at 100, 125, 150, and 180 bpm in six male mongrel dogs. Right atrial and femoral vein blood was obtained at baseline, and at 5, 12, 19, 26, 56, 86, 116, 146, and 206 minutes after right ventricular pacing. Resulting plasma concentration-time data derived parameters were compared. The disappearance rate constants for atrial and femoral venous proANF 1-98 were 0.0144 +/- 0.0087 (X +/- SD) and 0.0175 +/- 0.0075 min-1, respectively (t = 0.6158) and release rate constants were 0.1569 +/- 0.1504 and 0.0670 +/- 0.0393 min-1, respectively (t = 1.8269; P greater than .05). The proANF 31-67 disappearance rate constants were 0.0139 +/- 0.0082 and 0.0148 +/- 0.0132 min-1, respectively (t = 0.1192) and release rate constants were 0.0957 +/- 0.0414 and 0.1984 +/- 0.1762 min-1, respectively (t = 1.4812). The ANF elimination phase disappearance rate constants were 0.0663 +/- 0.0273 and 0.1116 +/- 0.0539 min-1 (t = 2.0923, P greater than .05), respectively, and the release rate constants were 0.1335 +/- 0.0532 and 0.1638 +/- 0.0520 min-1 (t = 0.7878, P greater than .05), respectively. These data indicate that proANF 1-98 and proANF 31-67 circulating beta post-distribution half-lives are approximately 45 minutes whereas beta half-life of ANF is 10 minutes.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Pharmacy Practice, University of Arkansas for Medical Sciences, Little Rock 72205-7122.
authors.forename: B H
authors.initials: BH
authors.lastname: Ackerman
authors.forename: R P
authors.initials: RP
authors.lastname: Wyeth
authors.forename: D L
authors.initials: DL
authors.lastname: Vesely
authors.forename: W L
authors.initials: WL
authors.lastname: Ngo
authors.forename: J K
authors.initials: JK
authors.lastname: Bissett
authors.forename: C J
authors.initials: CJ
authors.lastname: Winters
authors.forename: A L
authors.initials: AL
authors.lastname: Sallman
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000097:blood* / Q000493:pharmacokinetics; D002304:Cardiac Pacing, Artificial; D004285:Dogs; D006439:Hemodynamics; D008297:Male; D010446:Peptide Fragments / Q000493:pharmacokinetics*; D011863:Radioimmunoassay
chemical_list: D010446:Peptide Fragments; C055659:atrial natriuretic factor prohormone (1-98); D009320:Atrial Natriuretic Factor